000			01344 a2200409 4500
005			20250515031556.0
264		0	_c20060824
008			200608s 0 0 eng d
022			_a0735-7907
024	7		_a10.1080/07357900600705805 _2doi
040			_aNLM _beng _cNLM
100	1		_aFabi, A
245	0	0	_aDramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow? _h[electronic resource]
260			_bCancer investigation _c
300			_a466-8 p. _bdigital
500			_aPublication Type: Case Reports; Letter
650	0	4	_aAdult
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aBreast Neoplasms _xpathology
650	0	4	_aCapecitabine
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aFemale
650	0	4	_aFluorouracil _xanalogs & derivatives
650	0	4	_aHumans
650	0	4	_aMagnetic Resonance Imaging
700	1		_aVidiri, A
700	1		_aFerretti, G
700	1		_aFelici, A
700	1		_aPapaldo, P
700	1		_aCarlini, P
700	1		_aMirri, A
700	1		_aNuzzo, C
700	1		_aCognetti, F
773	0		_tCancer investigation _gvol. 24 _gno. 4 _gp. 466-8
856	4	0	_uhttps://doi.org/10.1080/07357900600705805 _zAvailable from publisher's website
999			_c16372474 _d16372474